The addiction treatment market in North America has been growing steadily over the past few years and is expected to continue its growth in the coming years due to several factors such as the rising prevalence of substance abuse disorders, growing public awareness about addiction and its treatment, and the availability of insurance coverage for addiction treatment. For instance, Texas Health and Human Services announced a public awareness campaign of 23.2 million USD in March 2022 to assist people get access to addiction treatment & services and prevent substance abuse disorders. Moreover, the legalization of cannabis in some states and the opioid epidemic have further contributed to the demand for addiction treatment services. The market is highly fragmented, with many leading players providing a range of services including inpatient and outpatient treatment, detoxification programs, counseling, and therapies. Also, advancements in new technologies such as telemedicine and online counseling, are expected to further propel the growth of the addiction treatment market in the region.

Access For Sample PDF- https://univdatos.com/report/addiction-treatment-market/get-a-free-sample-form.php?product_id=38209

Further, the North American Addiction Treatment Market was valued at USD 10 billion in 2021 & is expected to grow at a CAGR of 6% from 2022-2030. Advancements in medical technology and the development of new treatment methods, increased public awareness of addiction, and efforts to reduce the associated with seeking treatment have also contributed to the growth of the market. For instance, Texas Health and Human Services launched a $23.2 million public awareness campaign in March 2022 to help people get access to addiction treatment and services and prevent substance abuse disorders.

North America Addiction Treatment Market Revenue (2020-2030)- USD Mn

Addiction-Treatment-Market.png
Addiction Treatment Market

Based on treatment type, the market is segmented into alcohol addiction treatment, tobacco treatment, opioid treatment, and others. Among these, the alcohol addiction treatment category is to witness a higher CAGR during the forecast period. This is mainly due to alcohol addiction being a significant problem in the region, and the demand for alcohol addiction treatment services is high. For instance, as per National Institute on Alcohol Abuse and Alcoholism (NIAAA), around 14.5 million adults in the U.S. had alcohol use disorder (AUD) in 2019. The cost of AUD to the U.S. economy is estimated to be over USD 250 billion annually.

On the basis of treatment centers, the market is categorized into inpatient centers, residential centers, rehabilitation centers, and others. Among these, the inpatient centers held a significant share of the market in 2021. This is mainly due to growing awareness of the negative consequences of addiction and the need for effective treatment options. Also, the market is further drive due to these centers provide a wide range of services to individuals struggling with addiction such as detoxification, therapy, counseling, medication-assisted treatment, and other support services to help individuals overcome their addictions and achieve long-term recovery.

Global Addiction Treatment Market Segmentation

Market Insight, by Treatment Type

·        Alcohol Addiction Treatment

·        Tobacco Treatment

·        Opioid Treatment

·        Others

Market Insights, by Treatment Centers

·        Inpatient Center

·        Residential Centers

·        Rehabilitation Centers

·        Others

Market Insights, by Distribution Channel

·        Hospital Pharmacies

·        Medical Stores

·        Others

Market Insight, by Region

·        North America

o   U.S.

o   Canada

o   Rest of North America

·        Europe

o  Germany

o  UK

o  France

o  Italy

o  Spain

o  Rest of Europe

·        APAC

o  China

o  India

o  Japan

o  Rest of APAC

·        Rest of the World

Top Company Profiles

·        Cipla Inc.

·        Alkermes

·        Pfizer Inc.

·        Orexo AB

·        GSK plc.

·        Sandoz International GmbH

·        Reckitt Benckiser Group PLC

·        Teva Pharmaceutical Industries Ltd.

·        Novartis AG

·        Indivior PLC